Mortality in patients with Sanfilippo syndrome
Abstract Background Sanfilippo syndrome (mucopolysaccharidosis type III; MPS III) is an inherited monogenic lysosomal storage disorder divided into subtypes A, B, C and D. Each subtype is characterized by deficiency of a different enzyme participating in metabolism of heparan sulphate. The resultant...
Main Authors: | Christine Lavery, Chris J. Hendriksz, Simon A. Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-017-0717-y |
Similar Items
-
In silico Analysis of Candidate Genes Involved in Sanfilippo Syndrome
by: Mehreen Zaka, et al.
Published: (2015-04-01) -
Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease
by: Rachel Heon-Roberts, et al.
Published: (2020-01-01) -
Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III)
by: Nicole M. Muschol, et al.
Published: (2019-05-01) -
Epidemiology of Sanfilippo syndrome: results of a systematic literature review
by: Tamás Zelei, et al.
Published: (2018-04-01) -
Untypically mild phenotype of a patient suffering from Sanfilippo syndrome B with the c.638C>T/c.889C>T (p.Pro213Leu/p.Arg297Ter) mutations in the NAGLU gene
by: Karolina Pierzynowska, et al.
Published: (2020-09-01)